gastric dumping semaglutide Adjunctive in Patients Undergoing Intragastric Balloon for Weight Loss: 12-Month Prospective Comparative Study | Obesity Surgery Effect of Semaglutide on the
Description
Made in the USA in a GMP-certified facility
On average, people taking semaglutide (Wegovy) for weight management lose 10-15% of their body weight from baseline after 6 months
However, gastrointestinal side effects overall are very common , affecting more than 1 in 10 patients (10%) according to the MHRA-approved product information
1 Second, the comparison against other GLP-1 drugs: in an analysis of FDA adverse-event reports, semaglutide carried the highest constipation reporting signal of any GLP-1 receptor agonist (reporting odds ratio 6.17), ahead of liraglutide, dulaglutide, and the rest
